Success Metrics

Clinical Success Rate
75.0%

Based on 3 completed trials

Completion Rate
75%(3/4)
Active Trials
3(30%)
Results Posted
33%(1 trials)
Terminated
1(10%)

Phase Distribution

Ph phase_2
6
60%
Ph phase_3
1
10%
Ph not_applicable
1
10%
Ph phase_4
1
10%

Phase Distribution

0

Early Stage

6

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
6(66.7%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
1(11.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

3

trials recruiting

Total Trials

10

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(3)

Detailed Status

Completed3
Recruiting3
unknown2
Terminated1
Suspended1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
3
Success Rate
75.0%
Most Advanced
Phase 4

Trials by Phase

Phase 26 (66.7%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A1 (11.1%)

Trials by Status

terminated110%
unknown220%
completed330%
recruiting330%
suspended110%

Recent Activity

3 active trials
Showing 5 of 10
suspended

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

NCT06246344
completedphase_2

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

NCT05792735
recruitingphase_2

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

NCT06758830
recruitingnot_applicable

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

NCT05496491
terminatedphase_3

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

NCT02927938
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT06246344

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer

Suspended
NCT05792735Phase 2

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Completed
NCT06758830Phase 2

Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.

Recruiting
NCT05496491Not Applicable

Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial

Recruiting
NCT02927938Phase 3

Leukemia Stem Cell Detection in Acute Myeloid Leukemia

Terminated
NCT05274945Phase 2

Total Neoadjuvant Therapy Versus Standard Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer

Completed
NCT05054959Phase 2

Consolidation Versus Induction Chemotherapy in Total Neoadjuvant Therapy of Rectal Cancer With High Risk for Recurrence

Recruiting
NCT04664504Phase 2

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Unknown
NCT04747951Phase 4

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Unknown
NCT02084563Phase 2

Study of Molecular and Genetic Abnormalities in Patients With Myeloid Neoplasms

Completed

All 10 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
10